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F atty acids (FAs) appear to play a critical role in reproductive function and fertility (1, 2) , potentially through their role in prostaglandin synthesis, insulin sensitivity, inflammation, and steroidogenesis (3, 4) . Most research on FAs in relation to reproductive processes has focused on dietary FA intake; there is an increasing amount of data highlighting the role that dietary fat, and specific types of fat, have on various reproductive outcomes, including birth outcomes. Studies of dietary fat show that trans fats may increase the risk of endometriosis (5) , that total fat and polyunsaturated fatty acid (PUFA) intake is associated with small increases in testosterone concentrations in women, and that specific marine omega-3 FAs may be associated with a reduced risk of anovulation (6) . Omega-3 FAs have also been associated with an increased risk of fibroid development (7) but lower risk of menstrual pain (8) . Specific dietary fats may influence fertility through these effects on androgens, ovulation, or gynecologic conditions.
Studies on fertility are limited and have shown higher intake of trans FAs to be associated with a greater risk of ovulatory infertility (9) and reduced fecundity (10) . Findings from a case-control study in Spain and a cohort study in the Netherlands suggest that greater adherence to a Mediterranean diet may improve fertility outcomes, and the authors pointed to the high fat content of vegetable oil [rich in linoleic acid (LA; 18:2n6 c/c)] as part of the Mediterranean diet as the potential driving force behind this association (11, 12) . Furthermore, studies among women undergoing fertility treatments show the importance of omega 3 FAs (13) and the ratio of omega-6 to omega-3 FAs on pregnancy rates (14, 15) .
Although dietary FA intake in relation to reproductive function and infertility has been explored in several studies, how the physiological FA profile affects fertility is still unclear. Thus, we sought to examine the relationship between preconception plasma phospholipid fatty acid (PPFA) status and fecundability, as measured by time to pregnancy (TTP). Specifically, we examined plasma phospholipids and determined percentages of total FAs attributed to individual FAs and main FA subtypes, including saturated fatty acids (SFAs), monounsaturated fatty acids (MUFAs), PUFAs, trans fatty acids (TFAs), and omega-3 and omega-6 FAs in relation to TTP.
Materials and Methods

Study design
This was a secondary analysis of a prospective cohort from the Effects of Aspirin in Gestation and Reproduction (EAGeR) trial. The EAGeR trial was a multicenter, block-randomized, double-blind, placebo-controlled trial to investigate the effect of preconception-initiated daily low-dose aspirin on reproductive outcomes in women with a history of pregnancy losses (16) .
Between 2007 and 2011, 1228 women were enrolled who were 18 to 40 years old, had one or two documented prior pregnancy losses, had regular menstrual cycles of 21 to 42 days, and were trying to conceive without the use of fertility treatments.
The detailed study protocol is reported elsewhere (16) . Briefly, participants completed baseline questionnaires on demographics, lifestyle habits, medical and reproductive history, and family medical history prior to random assignment. Height and weight were measured to calculate body mass index (BMI; calculated as weight in kilograms divided by height in meters squared) at random assignment. Participants were followed for six menstrual cycles or throughout their pregnancy for those who became pregnant. The institutional review board at each study site (Salt Lake City, UT; Denver, CO; Buffalo, NY; Scranton, PA) and data coordinating center approved the trial protocol and all participants provided written informed consent prior to enrolling. The trial was registered at ClinicalTrials.gov (identifier: NCT00467363).
PPFAs analysis
Blood specimens were obtained at a baseline study visit and stored at 280°C until analysis. PPFAs were analyzed at the University of Minnesota using previously described methods (17) . For the extraction of phospholipid FAs, plasma was diluted in saline and lipids were extracted from a mixture of chloroform and methanol (2:1, volume for volume). Cholesterol, triglycerides, and phospholipid subclasses were separated on a silica thin-layer chromatography plate in a solvent mixture of petroleum ether, diethyl ether, and glacial acetic acid. The band of phospholipids was harvested for the formation of methyl esters, and the final product was dissolved in heptane and injected onto a capillary Varian CP7420 30-m column with a Hewlett Packard 5890 gas chromatograph (Wilmington, DE) equipped with a HP6890A autosampler (Santa Clara, CA). The gas chromatograph was configured for a single capillary column with a flame ionization detector and interfaced with HP chemstation software. Individual FAs were expressed as a percentage of total FAs. Coefficients of variation of FAs range from 2.1% for palmitic acid (16.0) 
Outcome assessment
The primary outcome of the current analysis was TTP or the number of menstrual cycles to achieve a pregnancy, a commonly used measure of fecundability. Pregnancy was determined by positive urine human chorionic gonadotropin (hCG) and ultrasound, as previously described (18) . In brief, a urine hCG test (Quickvue, Quidel Corp, San Diego, CA), which was sensitive to 25 mIU/mL hCG, was conducted each time participants reported missing menses on any end-cycle visit. In addition, urine hCG testing was performed later on daily firstmorning urine samples collected on the last 10 days of each woman's first and second cycles of study participation and on spot urine samples collected at all end-of-cycle visits. Among those women with a positive urine hCG test, ultrasound was performed to confirm pregnancy by detection of a gestational sac on ultrasound at 6 to 7 weeks of gestation or clinical recording of fetal heart rate.
Statistical analysis
For women who had preconception PPFAs measurement, we characterized the distribution of demographic and lifestyle factors by tertiles of PUFA, SFA, and MUFA. We also assessed the distributions of PPFAs.
We used Cox proportional hazard regression models for discrete survival time, accounting for left truncation (i.e., cycles trying to become pregnant prior to study start) and right censoring, to estimate fecundability ORs (FORs) and 95% CIs between FAs and TTP. FORs estimate the odds of becoming pregnant each cycle-given exposure, conditional on not being pregnant in the previous cycle. FORs ,1 denote a reduction in fecundity or a longer TTP, and FORs .1 denote a shorter TTP. Approximately 13% of women (n = 159) did not have preconception PPFAs measurement in our data. To account for missing data, we used multiple imputation by imputing missing FAs and covariates (i.e., age, race, BMI, smoking, physical activity, income, parity, total cholesterol concentration, and treatment arm) in five imputed data sets. We used the imputed data set (n = 1228) during the multivariable analysis. Models were adjusted for age, race, BMI, smoking, physical activity, income, parity, total cholesterol concentration, and treatment arm. BMI stratified models [BMI ,25 (underweight/normal weight) and $25 (overweight/obese) kg/m 2 ] were also adjusted for the same covariates. Models evaluated FAs continuously (per 1% increase in total composition) as well as FAs categorized by tertile. We accounted for multiple comparisons by adjusting all models for the false discovery rate (FDR) within categories of FAs [i.e., total plasma FAs (total SFAs, total MUFAs, total PUFAs), odd chain SFAs, even chain SFAs, TFAs, MUFAs, n-6 FAs, n-3 FAs, and ratios].
Dietary assessments were not available in this study, so we were unable to adjust for other dietary factors, such as total energy intake, directly. Thus, we performed a sensitivity analysis for unmeasured confounding across a range of scenarios to evaluate the impact of a possible unmeasured dietary factor, which could represent a factor such as fish consumption, or total energy that was not measured, on estimates of the association between FAs and TTP. Fish consumption was considered to be one such potential unmeasured confounder because fish consumption is strongly correlated with omega-3 FAs and environmental contaminants (19) (20) (21) (22) (23) , which are associated with fecundability (10, 24) . We hypothesize that total energy intake may also be associated with both FAs and fecundability and may thus act as a potential confounder. We simulated such a variable for a range of correlations between the unmeasured factor and TTP. Specifically, the association between the unmeasured dietary factor and TTP was set to be b = 20.7, 0.0, or 0.7, where a b = 0.1 corresponds to the FORs observed in the EAGeR Study for MUFAs and PUFAs, and the other variables represent a dietary factor with a strong harmful effect or strong beneficial effect on fecundability representing FORs from 0.5 to 2.0. The correlation between the unmeasured dietary or environmental factor and FAs varied between r = 0 and r = 0.8. Previous studies evaluating the correlation between FAs and fish intake showed correlations from 0.41 to 0.58 (23, 25, 26) , highlighting the realistic range of scenarios evaluated in this study. We compared results of our final adjusted models with those of models adjusted for this simulated dietary factor. We used SAS, version 9.4 (SAS Institute, Cary, NC) for all statistical analyses.
Results
Women in the highest tertile of PUFA tended to have lower BMIs on average and were less likely to drink alcohol often (four to seven times per week), be in lowincome categories (,$40,000/y), and be unemployed (Table 1) . No differences were observed between tertile of PUFAs and age, race, smoking, or physical activity. Women in the highest tertile of SFA were more likely to be overweight, be in low-income categories, and to have two previous live births. No differences were observed in age, race, smoking, alcohol consumption, physical activity, or education by tertile of SFA. Women in the highest tertile of MUFA had lower BMI on average, were more like to never drink, report high levels of physical activity, have completed more than high school education, and were less likely to be nulliparous. No differences were observed in age, race, smoking, income, and employment by tertile of MUFA. The average (SD) percent of total PFAs at baseline for this population was 39.4 (1.5) for SFA, 11.5 (1.2) for MUFA, and 43.2 (1.7) for PUFA (Table 2) .
Overall, we observed that MUFAs were associated with increased fecundability and PUFAs were associated with decreased fecundability after adjustment for confounders (Table 3) . These associations did not survive adjustment for the FDR. However, these associations were consistent among women with underweight/ normal-weight BMI and, among this group, the associations with MUFAs and PUFAs survived adjustment for FDR. No associations were observed among women with overweight/obese BMI. Furthermore, no associations were observed with SFAs or TFA and fecundability. Though certain individual FAs were associated with fecundability in unadjusted models, only DPA remained associated after adjustment and this association did not remain after adjustment for the FDR. Among normalweight women, the ratio of PUFA to SFA was associated with reduced fecundability, consistent with the observed findings with PUFA and SFA overall, though this was not significant after adjustment for the FDR. Similar results were observed when FAs were evaluated in tertiles, though an association with SFAs in the second and third tertile, compared with the first, was associated with reduced fecundability among women with overweight/ obese BMI (Supplemental Table 1 ).
To evaluate the potential for confounding by unmeasured dietary intake or environmental contaminants from fish intake, we performed a sensitivity analysis for unmeasured confounding. These results determined that the associations we observed between MUFAs and PUFAs and fecundability are unlikely to be explained by unmeasured confounding by other dietary factors such as fish consumption (Figs. 1 and 2 ). Sensitivity analyses showed that adjustment for a factor intending to represent unmeasured fish consumption across a range of effect estimates with TTP (b range, 20.7 to 0.7, corresponding to FOR range of 0.5 to 2) and any correlation with FAs (r = 0 to 0.8) did not have a significant effect on estimates. This is noted because all models that did not adjust for the unmeasured factor remained significant. In other words, even though we were unable to adjust for this potential factor, our current analyses did not yield results that could be explained by the potential confounding scenarios.
Discussion
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68 (20) 75 (21) 67 (19) 61 (18) 74 (21) 75 (21) 77 (22) 64 (18) This study extends previous work by evaluating PPFAs as markers of dietary intake among a large cohort of women with a history of pregnancy loss. Though similar associations were observed among the whole cohort, the associations for MUFAs and PUFAs only survived adjustment for the FDR among normal-weight women. These results highlight the importance of FA composition among normal-weight women with prior pregnancy loss. Although there are many studies examining FA profiles during pregnancy (27) (28) (29) (30) (31) (32) , few examined the effect of preconception FA profiles on fertility (9, 33). Our results are somewhat inconsistent with the limited prior research in this area. However, unlike our study, previous work was based on food frequency questionnaires for FA assessment, which may be limited by measurement error and recall bias, as well as the completeness of food composition databases for fat intake (34, 35). Our results showing the importance of MUFAs, particularly among normal-weight women, are in line with research on other health outcomes showing the benefits of MUFAs for reducing blood pressure (36) and cardiovascular disease (37) . A recent study by Wise et al. (10) observed that TFAs and omega-3 FAs were important for fecundability among two online cohorts of pregnancy planners. The Nurses Health Study II also found that type of fat intake was important and observed, using a food frequency questionnaire for fat intake assessment, that TFAs, in particular, were associated with ovulatory infertility (9). Though we did not observe associations with trans fats, it is important to recognize that the concentrations of TFAs in the EAGeR study were low, making up ,1% of total FAs; thus concentrations may not have been sufficient to affect fecundability. This may be in part because changes in the labeling requirements in the United States resulted in a substantial reduction in the intake of TFAs by the time the EAGeR trial was conducted. Importantly, these (38) (39) (40) (41) . Though one study observed associations with omega-3 FAs and fecundability, there was no dose response, and associations were only observed among one of the cohorts evaluated (10) . Among a small study of overweight and obese women undergoing in vitro fertilization, higher levels of PUFA intake, specifically omega-6 and with a trend for omega-3 FAs, were observed among women who became pregnant (33) . In the BioCycle study, PUFAs were associated with small increases in androgen concentrations, which may play a role in our findings because increased androgen concentrations are associated with polycystic ovary syndrome and anovulation (6) . Specific marine omega-3 FAs were marginally associated with ovulatory function, though no associations with TFAs were observed, which is consistent with our findings (6). We did not observe associations between specific marine omega-3 FAs and fecundability in the EAGeR trial, though perhaps any effects on ovulation were not strong enough to influence fecundability.
Our findings indicate that PUFA concentrations may potentially be detrimental to fecundability, particularly among normal-weight women, though associations suggested only an 8% decrease in fecundability. Possible mechanisms that may underlie these associations could be generally related to the fact that eicosanoids derived from n-6 PUFAs [LA (18:2n6 c/c) and AA (20:4n6)] are generally proinflammatory, whereas eicosanoids derived from n-3 PUFAs [EPA (20:5n3) and DHA (22:6n3)] are generally anti-inflammatory (42) . Furthermore, some studies suggest that PUFAs, and LA (18:2n6 c/c) in particular, may have adverse effects on proinflammatory cytokines and adhesion molecules (43) . In fact, in vitro models from animals and humans have shown PUFAs are associated with increased cellular oxidative stress (44-46). Reactive oxygen species play a critical role in cell development and apoptosis, and therefore are necessary for key reproductive steps, including folliculogenesis, ovulation, and placentation (47) . Oxidative stress may also influence hormone concentrations (48) and oxidative stress adversely influences reproductive outcomes (49) including, fertility, pregnancy loss, preeclampsia (50, 51) , intrauterine growth restriction, and polycystic ovary syndrome (52) . Given the small magnitude of the associations, and that associations remained only in the normal-weight group after adjustment for FDR, these findings warrant further study in other populations. Our findings that FAs are important for fecundability are consistent with hypotheses that FAs positively influence steroidogenesis. Omega-6 FAs, in particular, are precursors for prostaglandin synthesis and can modulate the expression of key enzymes involved in prostaglandin and steroid metabolism (2) . However, the role of PUFAs is complicated because omega-6 FAs may increase androgens, though supplementation with omega-3 FAs has been shown to decrease concentrations of bioavailable testosterone (53) , and serum long-chain omega-3 FA levels have been associated with improved fertility treatment outcomes (13) . The ratio of these two FAs may thus be important, as demonstrated in a study of women undergoing fertility treatment showing a greater ratio of omega-6 to omega-3 PUFAs associated with higher pregnancy rates (14) . However, we did not observe associations between the ratio and fecundability in this study. Androgens have been associated with certain ovulatory disorders and polycystic ovary syndrome (54); therefore, the role of PUFAs to decrease fecundability may be due to alterations in androgen synthesis. FAs may also influence fecundability through changes in insulin sensitivity and inflammation, because these pathways influence ovulatory function, as well (3, 4) .
There are several strengths and limitations of the present work. Importantly, FAs were assessed in plasma, which is a validated marker of short to medium exposure (;50 to 80 hours prior) to dietary fat intake for specific FAs (35, (55) (56) (57) . Though we were limited in having a single assessment at baseline, these measurements are less susceptible to measurement error due to recall of food intake and estimation of hidden fats, and studies suggest that dietary intake remains quite stable across pregnancy attempts (35, (58) (59) (60) . However, it is important to note that certain individual FAs have low correlations with long-term intake, and that our measurement was of percentage composition and not concentration. Traditional dietary assessments were not available to allow for adjustment for potential confounding by other dietary components that have been shown to influence fecundability and be related to dietary fat intake. However, we used a sensitivity analysis for unmeasured confounding and found that even after adjustment for a very strong potential unmeasured confounding factor, which could represent a dietary factor such as fish consumption or total energy consumption, among others, our results remained consistent. Thus, our findings are not likely explained by confounding from other dietary or environmental factors, including fish consumption. Our results for MUFAs and PUFAs also remained consistent in the normal-weight group after adjustment for multiple comparisons using the FDR. Furthermore, this study evaluated the association in a cohort of women attempting pregnancy with a history of one to two prior pregnancy losses and is limited in its generalizability to women with a similar reproductive history; however, it is important to note that a large proportion of reproductive age women experience pregnancy loss (estimated to be ;30%) and thus the group to which this is applicable is quite large (61, 62) .
We found that plasma FA composition was associated with fecundability among normal-weight women with prior pregnancy loss, highlighting the importance of MUFAs and PUFAs, in particular, for fecundability. Given the significant costs associated with assisted reproductive technologies (63) and the great psychological burden put upon women unable to achieve pregnancy (64) , there is great interest to identify modifiable diet and lifestyle factors that may improve a woman's fecundity. Further research is needed to confirm these findings to determine the optimal composition of FAs for fecundability to inform future supplementation trials. Disclosure Summary: The authors have nothing to disclose.
